Tritonix.ai

News / Korea / yonhap_finance

SkyLabs Shares Rise on KOSDAQ Debut After Early Volatility

Health Technology · Medical Specialties · yonhap_finance · 2026-09-04

386380

Medical device manufacturer SkyLabs saw its shares climb above its IPO price on its first day of trading on the KOSDAQ market.

What Happened

Market Debut: Medical device manufacturer SkyLabs successfully debuted on the KOSDAQ market, with its shares trading above the IPO price of 10,000 KRW during early morning sessions. Despite an initial dip shortly after the opening bell, the stock managed to rebound and maintain positive momentum.

Company Background: Established in 2015, SkyLabs specializes in the production of cuffless continuous blood pressure monitoring medical devices. The company is supported by Korea Investment & Securities, which served as the lead underwriter for the listing.

Financial Performance: For the previous fiscal year, the company reported consolidated revenue of 7.9 billion KRW and an operating loss of 14.7 billion KRW. These figures reflect the company's current phase of heavy investment in research and market expansion.

Investor Sentiment: The IPO process saw a competitive ratio of 63.41 to 1 during the institutional demand forecasting phase. While the stock experienced volatility upon listing, the subsequent recovery suggests ongoing interest from market participants.

Read original

More in Health Technology

Curacle Announces 100 Billion Won Rights Offering for Operational Funding

Health Technology · yonhap_finance · 2026-09-04

Curacle has decided to raise approximately 100 billion KRW through a rights offering to secure working capital, issuing 7.1 million new shares.

115180

Tech-Specialized Listing Scheme Reaches 300 Companies Milestone

Health Technology · yonhap_finance · 2026-09-04

The Korea Exchange's tech-specialized listing program has reached 300 companies 21 years after its inception, solidifying its role in KOSDAQ growth.

196170, 386380, 950200, 950220, 950250

Ennoconn Subsidiary AJ Bio Files for Phase III Clinical Trial of SBMA Drug

Health Technology · economic_daily · 2026-09-03

AJ Bio has submitted an IND application to the US FDA for its SBMA treatment, AJ201, aiming to leverage orphan drug status for global licensing deals.

7754

Latest in Korea

Kiwoom Securities Launches Naver Plus Store Integration with Up to 4% Point Rewards

Finance · yonhap_finance · 2026-09-04

Kiwoom Securities has introduced a new feature in its 'Youngwoongmun S#' app, allowing users to earn up to 4% in points on Naver Plus Store purchases.

039490

Curacle Announces 100 Billion Won Rights Offering for Operational Funding

Health Technology · yonhap_finance · 2026-09-04

Curacle has decided to raise approximately 100 billion KRW through a rights offering to secure working capital, issuing 7.1 million new shares.

115180

SoftBank Group Sets 4.75% Coupon for Record 1 Trillion Yen Retail Bond Issuance

Finance · yonhap_finance · 2026-09-04

SoftBank Group is issuing 1 trillion yen in retail bonds at a 4.75% coupon, marking the largest retail bond offering by a Japanese company to date.

US Senate Proposes Bill Allowing Private Firms to Conduct Military Cyber Operations

Technology Services · yonhap_finance · 2026-09-04

The US Senate is pushing to include a pilot program in the NDAA that would authorize private companies to execute military cyber operations under US Cyber Command.